EGF-Like Domain of Tenascin-C Is Proapoptotic for Cultured Smooth Muscle Cells

Objective—Based on our previous observations on the expression of Tenascin-C (Tn-C) in human atherosclerotic plaques and its colocalization with macrophages, we explored whether Tn-C undergoes fragmentation and the potential pathobiological significance of this fragmentation. Methods and Results—Using cultured human smooth muscle cells (SMCs), we found that Tn-C upregulates expression of matrix metalloproteinases (MMPs). Western blot analysis revealed that Tn-C substrate is fragmented and most of the cleavage products have fibronectin-like and epidermal growth factor-like (EGF-like) domains of Tn-C. One fragment that contains an EGF-like domain was found in some human atherosclerotic plaques. Cell culture studies revealed that the recombinant EGF-like domain inhibits growth, induces apoptosis of SMCs in a dose-dependent, time-dependent, and caspase-dependent manner, and activates caspase-3 before SMC detachment. Conversely, the caspase inhibitor z-YVAD.cmk, serum, and protease inhibitors blocked cell apoptosis conferred by the EGF-like domain. In addition, these inhibitors blocked EGF-like domain-induced caspase-3 activation. In contrast to this EGF-like domain, intact Tn-C, its fibronectin-like, and its fibrinogen-like domains were inactive. Conclusions—Together with our previous observations, our data suggest that Tn-C upregulates MMP expression that cleaves Tn-C into fragments containing the EGF-like domain. This domain has proapoptotic activity for SMCs.

[1]  P. Biglioli,et al.  Evidence for a Proinflammatory and Proteolytic Environment in Plaques From Endarterectomy Segments of Human Carotid Arteries , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Kenneth M. Yamada,et al.  Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. , 2001, Journal of cell science.

[3]  E. Mulvihill,et al.  α1-Proteinase Inhibitor, α1-Antichymotrypsin, and α2-Macroglobulin Are the Antiapoptotic Factors of Vascular Smooth Muscle Cells* , 2001, The Journal of Biological Chemistry.

[4]  E. Clark,et al.  Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[5]  K. Fujikawa,et al.  α1-Proteinase Inhibitor, α1-Antichymotrypsin, or α2-Macroglobulin Is Required for Vascular Smooth Muscle Cell Spreading in Three-dimensional Fibrin Gel* , 2000, The Journal of Biological Chemistry.

[6]  R. Virmani,et al.  Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[7]  K. Walsh,et al.  Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[8]  A. Becker,et al.  Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques , 1999, The Journal of pathology.

[9]  M. Carlson,et al.  Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. , 1999, Experimental cell research.

[10]  S. Kaul,et al.  Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. , 1999, Circulation.

[11]  A. Becker,et al.  Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? , 1999, Cardiovascular research.

[12]  C. Damsky,et al.  Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis , 1998, The Journal of cell biology.

[13]  P. Shah,et al.  Aortic Smooth Muscle Cells Interact with Tenascin-C through Its Fibrinogen-like Domain* , 1997, The Journal of Biological Chemistry.

[14]  P. Libby,et al.  Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[15]  G. Giannelli,et al.  Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. , 1997, Science.

[16]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation. , 1997, Experimental cell research.

[17]  Y. Okada,et al.  Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. , 1997, The Biochemical journal.

[18]  M. Matter,et al.  Inhibition of pp125FAK in cultured fibroblasts results in apoptosis , 1996, The Journal of cell biology.

[19]  J. Becker,et al.  Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. , 1996, The Journal of clinical investigation.

[20]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[21]  J. Isner,et al.  Apoptosis in human atherosclerosis and restenosis. , 1995, Circulation.

[22]  L. Zardi,et al.  Different Susceptibility of Small and Large Human Tenascin-C Isoforms to Degradation by Matrix Metalloproteinases (*) , 1995, The Journal of Biological Chemistry.

[23]  P. Libby,et al.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Y. Okada,et al.  Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases , 1994, FEBS letters.

[25]  C. Reutelingsperger,et al.  Expression on B Cells Undergoing Apoptosis Annexin V for Flow Cytometric Detection of Phosphatidylserine , 2022 .

[26]  S. Rubin,et al.  Cloning and characterization of alternatively spliced isoforms of rat tenascin. Platelet-derived growth factor-BB markedly stimulates expression of spliced variants of tenascin mRNA in arterial smooth muscle cells. , 1994, The Journal of biological chemistry.

[27]  Z. Werb,et al.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. , 1994, Molecular biology of the cell.

[28]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[29]  P. Libby,et al.  Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesions a , 1994, Annals of the New York Academy of Sciences.

[30]  H. Erickson,et al.  Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. , 1993, The Journal of biological chemistry.

[31]  J. Forrester,et al.  Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. , 1992, The Journal of biological chemistry.

[32]  V. Fadok,et al.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.

[33]  D. Bigner,et al.  Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy , 1989, The Journal of cell biology.

[34]  G M Edelman,et al.  A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Fujikawa,et al.  Alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, or alpha(2)-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin gel. , 2000, The Journal of biological chemistry.

[36]  J. Isner,et al.  Reduced Intimal Thickening Following αvβ 3 Blockade is Associated with Smooth Muscle Cell Apoptosis , 1998 .